| Product Code: ETC9205522 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market - Industry Life Cycle |
3.4 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market - Porter's Five Forces |
3.5 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.9 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
4 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision healthcare |
4.2.2 Technological advancements in next-generation sequencing (NGS) technologies |
4.2.3 Growing prevalence of genetic disorders and chronic diseases in Serbia |
4.3 Market Restraints |
4.3.1 High cost associated with NGS testing procedures |
4.3.2 Lack of skilled professionals to perform and interpret NGS tests in Serbia |
4.3.3 Regulatory challenges and lack of clear guidelines for NGS testing in the clinical setting |
5 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Trends |
6 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market, By Types |
6.1 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Sequencing By Synthesis, 2021- 2031F |
6.1.4 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Ion Semiconductor Sequencing, 2021- 2031F |
6.1.5 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Single-Molecule Real-time Sequencing, 2021- 2031F |
6.1.6 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Nano Pore Sequencing, 2021- 2031F |
6.1.7 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other Sequencing Technologies, 2021- 2031F |
6.2 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.2.3 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Drug Discovery, 2021- 2031F |
6.2.4 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Agricultural and Animal Research, 2021- 2031F |
6.2.5 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other Applications, 2021- 2031F |
6.3 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Academic Institutes and Research Centres, 2021- 2031F |
6.3.3 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.3.4 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F |
6.3.5 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other End Users, 2021- 2031F |
6.4 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market, By Service |
6.4.1 Overview and Analysis |
6.4.2 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Human Genome Sequencing, 2021- 2031F |
6.4.3 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Single Cell Sequencing, 2021- 2031F |
6.4.4 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Microbial Genome-based Sequencing, 2021- 2031F |
6.4.5 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Gene Regulation Services, 2021- 2031F |
6.4.6 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Animal and Plant Sequencing, 2021- 2031F |
6.4.7 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other Sequencing Services, 2021- 2031F |
6.5 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market, By Workflow |
6.5.1 Overview and Analysis |
6.5.2 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.5.3 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.5.4 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Data Analysis, 2021- 2031F |
7 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Import-Export Trade Statistics |
7.1 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Export to Major Countries |
7.2 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Imports from Major Countries |
8 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Key Performance Indicators |
8.1 Average turnaround time for NGS testing results |
8.2 Rate of adoption of NGS testing by healthcare providers in Serbia |
8.3 Number of research collaborations and partnerships for NGS testing advancements |
9 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market - Opportunity Assessment |
9.1 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Service, 2021 & 2031F |
9.5 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Workflow, 2021 & 2031F |
10 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market - Competitive Landscape |
10.1 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Revenue Share, By Companies, 2024 |
10.2 Serbia Clinical Next-Generation Sequencing (NSG) Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here